| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |